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Abstract
Background: Gestational diabetes mellitus is associated with increased incidence of adverse perinatal outcomes
including newborns large for gestational age, macrosomia, preeclampsia, polyhydramnios, stillbirth, and neonatal
morbidity. Thus, fetal growth should be monitored by ultrasound to assess for fetal overnutrition, and thereby, its
clinical consequence, macrosomia. However, it is not clear which reference curve to use to define the limits of
normality. Our aim is to determine which method, INTERGROWTH21st or customized curves, better identifies the
nutritional status of newborns of diabetic mothers.
Methods: This retrospective cohort study compared the risk of malnutrition in SGA newborns and the risk of overnutrition
in LGA newborns using INTERGROWTH21st and customized birth weight references in gestational diabetes. The nutritional
status of newborns was assessed using the ponderal index. Additionally, to determine the ability of both methods in the
identification of neonatal malnutrition and overnutrition, we calculate sensitivity, specificity, positive predictive value, negative
predictive value and likelihood ratios.
Results: Two hundred thirty-one pregnant women with GDM were included in the study. The rate of SGA indentified by
INTERGROWTH21st was 4.7% vs 10.7% identified by the customized curves. The rate of LGA identified by INTERGROWTH21st
was 25.6% vs 13.2% identified by the customized method. Newborns identified as SGA by the customized method showed
a higher risk of malnutrition than those identified as SGA by INTERGROWTH21st. (RR 4.24 vs 2.5). LGA newborns according to
the customized method also showed a higher risk of overnutrition than those classified as LGA according to
INTERGROWTH21st. (RR 5.26 vs 3.57). In addition, the positive predictive value of the customized method was
superior to that of INTERGROWTH21st in the identification of malnutrition (32% vs 27.27%), severe malnutrition
(22.73% vs 20%), overnutrition (51.61% vs 32.20%) and severe overnutrition (28.57% vs 14.89%).
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Conclusions: In pregnant women with DMG, the ability of customized fetal growth curves to identify newborns with
alterations in nutritional status appears to exceed that of INTERGROWTH21st.
Keywords: Small for gestational age (INFANT SGA), Fetal macrosomia, Diabetes, Gestational (gestational diabetes), Birth
weight, Fetal growth, Fetal malnutrition, Infant overnutrition
Background
Gestational diabetes mellitus (GDM) is associated with in-
creased incidence of adverse perinatal outcomes including
newborns large for gestational age (LGA), macrosomia
[1–4], preeclampsia [5], polyhydramnios, stillbirth, and
neonatal morbidity [6]. Newborns of mothers with GDM
are heavier and have greater skinfold measures and adi-
posity than offspring of mothers without GDM. Later in
life, children of diabetic mothers more frequently develop
early overweight or obesity, type 2 diabetes, and metabolic
syndrome [7–9].
In pregnant woman with GDM, ultrasound is used to
monitor growth as overnutrition is common and influ-
ences management. Prenatally, fetal overgrowth is sus-
pected when the ultrasound estimated fetal weight
(EFW) is abnormally elevated. An EFW higher than the
90th centile indicates an LGA fetus. In preterm fetuses,
this method is more accurate than that based only on
the absolute value of the EFW (EFW greater than 4000
or 4500 g) [10]. By considering gestational age at the
time of ultrasound, excessive fetal growth can be identi-
fied before the term [11].
Traditionally, fetal growth has been evaluated by compar-
ing estimated fetal weight with population-based reference
curves. Similarly, recent reports of the INTERGROWTH21st
Project recommend using a single standard for fetal growth
and birthweight [12–14].
Alternatively, a customized approach that uses a math-
ematical model of maternal anthropometric variables to
predict the optimal weight at term of each fetus has
gained strength recently [15, 16]. This optimal weight at
term can be combined with a fetal proportionality
weight curve to calculate a customized curve for each
mother in each pregnancy that can be used to predict
birth weight and fetal growth [17].
A few studies have compared INTERGROWTH21st
and customized curves ability to identify fetuses at high
risk of adverse perinatal outcomes, but not their ability to
identify alterations in neonatal nutritional status [17–21].
In this study, we used the ponderal index (PI) to assess the
nutritional status of newborns of GDM mothers. We hy-
pothesized that, in pregnant women with GDM, custom-
ized curves identify the nutritional status of the newborn
more accurately than INTERGROWTH21st. This study
aims to determine which method, INTERGROWTH21 or
customized curves, better identifies newborns with an
abnormal PI, as an indicator of the nutritional status of
newborns of diabetic mothers.
Methods
Design
This historical cohort study was conducted at the
Department of Obstetrics and Gynecology of the Univer-
sity Hospital of Puerto Real (Cádiz/Spain). Medical re-
cords of all consecutive singleton births that occurred
from January 2016 through March 2018 were retrieved
from our database of information prospectively col-
lected. Only pregnant women with GDM were included
in the study. Congenital anomalies or stillborn babies
were excluded from our study because of possible
changes in fetal and birth weights. Gestational age was
established based on the last menstruation and first
ultrasound (usually at 11–12 weeks). In cases where the
gestational age by ultrasound differed by ≥1 week, the
last menstruation was corrected and stored in the infor-
mation system.
Accepting an alpha risk of 0.05 and a beta risk of 0.2
in a one-sided test, 39 exposed subjects (SGA and LGA)
and 195 in the non-exposed (AGA) are necessary to
recognize as statistically significant a relative risk greater
than or equal to 3. A proportion of abnormal PI in the
exposed group has been estimated to be 0.1.
An exhaustive explanation of our customized method
can be found in the study published by Fernández Alba
et al. [22]. This method (based on the one proposed by
Gardosi) [16], predicts the weight that the newborn will
have at 40 weeks based on fetal sex and maternal vari-
ables (age, height and weight at the beginning of preg-
nancy). Next, the weight at each gestational age is
calculated as a proportion of the weight at 40 weeks, ac-
cording to the proportionality curve proposed by Had-
lock et al. [23]
To compare the two identification methods (INTER-
GROWTH21st and customized), two analyses were
performed:
1. Determination of the risk of alterations in the
nutritional status of the newborn (malnutrition or
overnutrition). To calculate the risk of neonatal
malnutrition, the exposed group included newborns
classified as small for gestational age (SGA) and the
reference group included newborns classified as
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appropriate for gestational age (AGA). The same
analysis was performed twice: one using
INTERGROWTH21st as the curve of reference and
another using our customized fetal growth curves
as the reference. To calculate the risk of neonatal
overnutrition and severe neonatal overnutrition, the
exposed group included newborns classified as LGA
and the reference group included newborns
classified as AGA. Again, the analysis was
performed twice: once using the INTERGROWTH
reference method and the other using our
customized curves. To check if there were
statistically significant differences, the risks obtained
were compared using the method proposed by
Altman and Bland [24].
2. Determination of the sensitivity, specificity, positive
predictive value (PPV), negative predictive value
(NPV), positive likelihood ratio (LR+), negative
likelihood ratio (LR-) and receiver operating
characteristic (ROC) curves of both methods for
identifying the nutritional status of the newborn.
3. Comparison of the ROC curves using the method
proposed by deLong [25].
Definitions
The diagnosis of GDM was established when at least two
of the following four plasma glucose levels (measured at
fasting, 1 h, 2 h, and 3 h after a 100 g oral glucose tolerance
test) were equal to or greater than 105mg/dL, 190mg/dL,
165mg/dL and 145mg/dL, respectively.
According to birth weight, newborns were classified as
SGA (birthweight <10th centile), AGA (birthweight be-
tween 10th and 90th centile), or LGA (birthweight >90th
centile) both by INTERGROWTH21st curves and by
our customized curves.
The nutritional status of the newborn was evaluated
using the ponderal index (PI) of Rohrer [26] adjusting by
sex and gestational age. Proposed by Rohrer, the PI indi-
cates how heavy a newborn is relative to its length [27–
30]. The formula is as follows: PI = (weight in g × 100)/
(length in cm)3. Because the PI relates to weight and
length, it indicates body proportions, thus providing in-
formation about the nutritional status of newborn [31].
The height of the newborns was measured using a talli-
meter of the SECA® brand model 210 with a graduation
measuring range of 5 mm.
Neonatal malnutrition was defined as the PI <10th
centile; a PI between the 10th percentile and 90th centile
was classified as normal; and a PI >90th centile was clas-
sified as neonatal overnutrition.
Statistical analyses
Categorical data were summarized as counts and per-
centages. The distributions of continuous data were
assessed using the Shapiro-Wilk test. Continuous data
with a normal distribution were summarized as mean
and standard deviation; by contrast, when the data
showed a non-normal distribution, we used the median
and the interquartile range as a measure of central
tendency.
The χ2-test was used to evaluate the differences in the
frequency of SGA and LGA newborns according to each
classification method.
The risks of malnutrition in newborns classified as
SGA, by the INTERGROWTH21st and by our custom-
ized method, were calculated. Likewise, the risks of over-
nutrition in newborns classified as LGA by these two
methods were calculated. The results were expressed as
relative risk (RR) and 95% confidence interval (95% CI).
The RR thus obtained were compared to each other to
verify if there were statistically significant differences. To
do this, we calculate the difference between the log of
RR and the standard error of this difference. Then a test
of interaction was obtained obtaining a z-score and its
corresponding p value [24].
The, PPV, NPV, sensitivity, specificity, LR+ and LR-
for the identification of malnutrition and overnutrition
were calculated for newborns classified as SGA and LGA
by both methods (INTERGROWTH21st and customized
curves). Finally, the ROC curves corresponding to each
method were prepared and compared with each other
using the method proposed by deLong [25].
A p-value less than 0.05 was deemed statistically sig-
nificant. All statistical analyses were performed using R
statistical software v. 3.5.2 [32].
Results
This study recruited 234 pregnant women with GDM. In
3 cases the length of the newborn was missing, so 231
women remained in the study.
The maternal characteristics and perinatal outcomes
are displayed in Table 1. The mean PI was 2.68 (SD:
0.26). The results of neonatal nutritional status are
shown in Table 2. The incidence of newborns with a PI
<10th centile was 8.7%, and the incidence of newborns
with a PI >90th centile was 13.9%.
Table 3 shows the distribution of SGA, AGA and LGA
newborns identified by each, INTERGROWTH21st and
the customized, method. The rate of SGA newborns iden-
tified by INTERGROWTH21st was 4.8% versus 10.8%
identified by our customized method. The rate of LGA
newborns identified by INTERGROWTH21st was 26% vs
13.4% identified by the customized method (p < 0.001).
Most newborns classified as SGA by INTER-
GROWTH21st also were identified as SGA by the cus-
tom method (10 of 11). However, of the 25 newborns
classified as SGA by the customized method, only 40%
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(10) was classified as SGA by INTERGROWTH21st and
the remaining 60% was classified as AGA.
Ten of the 11 newborns classified as SGA according to
INTERGROWTH21st were classified as SGA and 1 as AGA
according to the custom method. In contrast, 48.3% of the
60 newborns classified as LGA according to INTER-
GROWTH21st were classified as AGA according to the cus-
tom method and only 51.7% were classified as LGA.
On the other hand, only 10 (40%) of the 25 newborns
classified as SGA by the custom method were also classi-
fied as SGA by INTERGROWTH21st and the remaining
60% was classified as AGA. 100% of newborns classified
as LGA by the custom method were also classified as
LGA by INTERGROWTH21st.
The risk of presenting a PI <10th centile in newborns
classified as SGA by customized curves was 4.24 times
that of newborns classified as AGA (RR 4.24, 95% CI
1.93–9.33). Using INTERGROWTH21st the newborns
classified as SGA had 2.5 times of presenting a PI <10th
centile than those classified as AGA but, with this method,
the risk was not statistically significant (RR 2.5, 95% CI
0.85–7.31). Although the risk of malnutrition was higher
in SGA using the customized method, the test of inter-
action between the log of the relative risks was not statisti-
cally significant (z-score = − 0.831; p = 0.2).
Table 1 Maternal characteristics and perinatal outcomes
Variable Value
Maternal age (years): 34.59 (4.7) *
Maternal weight at the beginning of pregnancy
(kg):
69 (25) **
Maternal height (cm): 162.56 cm (6.13) *
Maternal BMI at the beginning of gestation (kg/
m2):
25.92 kg/m2 (8.62)
**
- Underweight (BMI < 18.5) 8 (3.4%) ***
- Normal BMI (18.5–24.9) 94 (40.2%) ***
- Overweight (BMI 25–29.9) 61 (26.1%) ***
- Obesity (BMI≥ 30) 71 (30.3%) ***
Hypertensive disorders of pregnancy 11 (4.8%) ***
- Gestational hypertension 5 (2.2%) ***
- Chronic hypertension 5 (2.2%)
- Preeclampsia 1 (0.4%)
Management of gestational diabetes
glycemic control with diet and exercise 151 (65.4%) ***
Insulin required 80 (34.6%) ***
Gestational age at birth (weeks): 39 weeks (2) **
- < 34 weeks 5 (2.1%) ***
- 34–34 + 6 weeks 12 (5.1%) ***
- 37–40 + 6 weeks 198 (84.6%) ***
- ≥ 41 weeks 19 (8.1%) ***
Neonatal gender
- Female 102 (43.6%) ***
- Male 132 (56.4%) ***
Birth weight (g) 3302 (506.47) *
Birth length (cm) 49.68 cm (2.19) *
Apgar score at 1 min
< 7 8 (3.5%) ***
≥ 7 223 (96.5%) ***
Apgar score at 5 min
< 7 0
≥ 7 231 (100%) ***
SD Standard deviation, IQR Interquartile range, BMI Body Mass Index
* Mean and standard deviation; ** Median and interquartile range; ***
Absolute frequency and percentage
Table 2 Nutritional status at birth
Nutritional status at birth N (%)
Malnutrition (PI < 10th centile) 20 (8.7%)
- Non-severe malnutrition (PI between 3rd and 10th
centile)
11 (4.8%)
- Severe malnutrition (PI <3rd centile) 9 (3.9%)
Norm nutrition (PI between 10th and 90th centile) 179
(77.5%)
Overnutrition (PI > 90th centile) 32 (13.9%)
- Non-severe overnutrition (PI between 90th and 97th
centile)
24 (10.4%)
- Severe overnutrition (PI >97th centile) 8 (3.5%)
PI Ponderal index
Table 3 Birthweight distribution classified by
INTERGROWTH21st and the customized method and proportion
of newborns with PI <10th centile, normal PI and PI>90th
centile in each of the groups
INTERGROWTH21st Customized
method
SGA: N (%) 11 (4.8%) 25 (10.8%)
PI <10th centile 3 (27.3% of IG SGA) 8 (32% of CM SGA)
PI between 10th and
90th centile
8 (72.7% of IG SGA) 17 (68% of CM SGA)
PI >90th centile 0 0
AGA: N (%) 160 (69.3%) 175 (75.8%)
PI <10th centile 16 (10% of IG AGA) 12 (6.9% of CM AGA)
PI between 10th and
90th centile
131 (81.9% of IG AGA) 147 (84% of CM AGA)
PI >90th centile 13 (8.1% of IG AGA) 16 (9.1% of CM AGA)
LGA: N (%) 60 (26%) 31 (13.4%)
PI <10th centile 1 (1.7% of IG LGA) 0
PI between 10th and
90th centile
40 (66.7% of IG LGA) 15 (48.4% of CM LGA)
PI >90th centile 19 (31.7% of IG LGA) 16 (51.6% of CM LGA)
SGA Small for gestational age, AGA Adequate for gestational age, LGA Large
for gestational age, PI Ponderal Index, IG INTERGROWTH21st, CM
Customized method
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It is important to note that, in the overlap, 33.3% of
children classified as SGA according to the customized
method and as AGA according to INTERGROWTH21st
had an PI below the 10th centile.
Newborns classified as LGA, either both by INTER-
GROWTH21st or by the customized method, had a
greater risk of presenting a PI >90th centile. However, the
RR of overnutrition in newborns classified as LGA by the
customized method was higher (RR: 5.26, 95% CI: 2.95–
9.36) than that of newborns classified as LGA by INTER-
GROWTH21st (RR 3.57, 95% CI: 1.89–6.74). Again, the
comparison of the logarithms of both risks (INTER-
GROWTH21st and custom method) showed that the dif-
ferences found between both methods were not
statistically significant (z-score = − 0.884; p value = 0.19).
It is important to clarify that, in the overlap, 86.2% of
children classified as LGA by INTERGROWTH21st and
as AGA by the custom method presented a normal IP
and only 10.3% presented a PI>90th centile.
Table 4 shows the ability of INTERGROWTH21st
and our customized method to identify a PI <10th cen-
tile in newborns classified as SGA or a PI >90th centile
in newborns classified as LGA. Identifying malnutrition,
both PPV and NPV were superior using the customized
method than using INTERGROWTH21st.
Figure 1 shows the ROC curves of both methods for
the detection of a PI <10th centile. The AUC obtained
with INTERGROWTH21st was 0.550 while using the
custom method we obtained an AUC of 0.648. Although
the customized method obtained a higher AUC, the
comparison of both curves using the deLong method
showed that the differences found were not statistically
significant (p = 0.18).
Identifying children with a PI > p90 (overnutrition) the
PPV of the customized method to was significantly
higher than that of INTERGROWTH21st. For detecting
overnutrition, the PPV of the customized method was
51.61% (95% CI 32.41–70.82) versus 32.20% (95% CI
19.43–44.97) for INTERGROWTH21st. However, NPVs
of the two methods were very similar.
Identifying overnutrition (PI>90th centile), the LR+ of
the customized method was superior for identifying
newborns with a PI > p90.
Figure 2 shows the ROC curves obtained by both
methods in the identification of newborns with a PI
>90th centile. The customized method obtained an AUC
that was slightly higher than that obtained by INTER-
GROWTH21st (0.71 vs. 0.68). However, this difference
was not statistically significant (p = 0.72).
Discussion
The classification of fetal nutritional status via an appro-
priate ultrasound standard is important to guide preg-
nancy management. A fetus incorrectly classified as SGA
or LGA will induce the clinician to intensify the moni-
toring of the pregnant woman and, in the specific case
of the GDM, even to modify the diet or treat with insu-
lin. Therefore, we believe that the clinician should
choose the curve that best identifies newborns with true
alterations in nutritional status (malnutrition or
overnutrition).
This study shows that in newborns of mothers with GDM,
the rates of SGA and LGA differ by the reference curve used,
INTERGROWTH21st or customized. The SGA rate using
INTERGROWTH21st was 4.8%, significantly lower than
10.8% observed using customized curves. In contrast, the
LGA rate using INTERGROWTH21st was 26%, compared
to 13.4% using our customized curves as the reference.
Therefore, in our population, the customized method identi-
fies more SGA while INTERGROWTH21st identifies more
LGA.
These SGA results were consistent with those recently
published by Francis et al. [15] who reported overall
SGA and LGA rates of 10.5 and 9.5%, respectively, using
customized curves. Using INTERGROWTH21st Francis
et al. observed an overall SGA rate, 4.4%, very similar to
the 4.7% rate of our sample and, like our study, they find
an unexpectedly high LGA rate of 20% (Similar to our
25%, if we take into account that we have analyzed a dia-
betic population).
Similarly, Anderson et al. [21], reported a significantly
lower SGA rates using INTERGROWTH21st versus cus-
tomized curves (4.5% vs 11.6%); additionally, in their co-
hort, Anderson et al. had a customised LGA rate of 8.9%
and INTERGROWTH21st LGA rate of 20.8%, with wide
variation by ethnicity (European women 23.7%, Indian
6.8% and Pacific 32.%) [NH Anderson, personal
communication].
The use of PI to assess the nutritional status of the
newborn presents certain limitations as it not only eval-
uates fat mass, but also head size, lean mass and bone
mass, hence potentially limiting its accuracy in reflecting
adiposity. However, accurate measures of body compos-
ition are usually costly. A recent work published by
Chen et al. [33] informs us that although skinfold mea-
sures may have more discriminative power in terms of
total body adiposity, simple anthropometric measures
(like PI) correlated strongly with neonatal adiposity and
conclude that these simple measures could be of value
in large epidemiological studies.
We found that the SGA and LGA classifications by
each method (customized vs INTERGROWTH21st) re-
flect differences in their ability to identify true alter-
ations in the PI as an indicator of the neonatal
nutritional status.
The RR of malnutrition (PI <10th centile) in newborns
classified as SGA by customized curves was higher, than that
of newborns classified as SGA by INTERGROWTH21st.
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This may be since 33.3% of children classified as SGA by the
customized method, but as AGA by INTERGROWTH21st,
had a PI <10th centile (suggestive of malnutrition). In any
case, when we compare both RR, we did not find a statisti-
cally significant difference (p = 0.2).
Likewise, the accuracy of the customized curves for
identification of newbornt with a PI <10th centile was
greater than that of INTERGROWTH21st, LR + of 3.86
vs 2.74, respectively. That is, using customized curves, it
is 3.86 times more likely that a malnourished newborn is
classified as SGA than a normally nourished newborn is
classified as SGA.
In a previous study by our team [22], carried out in an
unselected population, the customized method was su-
perior to the population-based for the identification of
newborns with a PI at birth <10th centile. This
superiority of the customized method was more evident
in the highest scales of maternal weight and height.
Owen et al. [34] found a similar relationship between
customized birth weight percentiles and neonatal malnu-
trition, but concluded that, in a low-risk population, the
customized curves are only moderately useful in the
identification of neonates with a low PI, with a positive
likelihood ratio of 4.3 (95% CI: 2.5–7.1). Agarwal et al.
[35] also found that the PI at birth was lower in new-
borns classified as SGA by customized curves than in
SGA according to population curves. The apparent su-
periority of the customized method to detect a PI <10th
centile should be interpreted with caution since the dif-
ference found between the RR was not statistically sig-
nificant and when comparing the ROC curves of both
methods the difference found was not statistically
Table 4 Sensitivity, specificity, predictive values and likelihood ratios of the INTERGROWTH21st and customized methods for
identification of neonatal malnutrition and overnutrition
Malnutrition (PI < 10th centile) Overnutrition (PI > 90th centile)
INTERGROWTH21st
SGA
Customized method
SGA
INTERGROWT21st
LGA
Customized method
LGA
Sensitivity 15.79% (0–34,82) 40% (16.03–63.97) 59.38% (40.80–77.95) 50% (31.11–68.89)
Specificity 94.24% (90.01–98.48) 89.63% (84.66–94.60) 76.61 (69.97–83.25) 90.74% (85.97–95.51)
PPV 27.27% (0–58,14%) 32% (11.71–52.29) 32.20% (19.43–44.97) 51.61% (32.41–70.82)
NPV 89.12% (34.74–94.49) 92.45 (88.03–96.87) 90.97% (85.94–96.00) 90.18% (85.31–95.06)
LR+ 2.74 (0.80–9.45) 3.86 (1.92–7.77) 2.54 (1.71–3.77) 5.40 (2.98–9.78)
LR- 0.89 (0.73–1.09) 0.67 (0.47–0.96) 0.53 (0.35–0.81) 0.55 (0.39–0.78)
PI ponderal index, SGA Small for gestational age, LGA Large for gestational age, PPV Positive predictive value, NPV Negative predictive value, LR+ Positive
likelihood ratio, LR- Negative likelihood ratio
Fig. 1 ROC curves of INTERGROWTH21st and customized method in the identification of malnourished newborns. Newborns classified as SGA or
AGA have been included for each of the methods, setting the 10th centile as a cut-off point. The test has been considered positive when the
birth weight index has been below 10th centile
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significant. The reality is that, with the prevalence of
malnutrition found in the sample (8.9%) we would need
at least 1200 individuals to reach a statistical power of
80%. This shows that the statistical non-significance
could be due to an insufficient sample size.
Similarly, the RR of overnutrition (PI>90th centile) as-
sociated with LGA classification by customized curves,
RR 5.26, was greater than in the newborns classified as
LGA by INTERGROWTH21st, RR 3.57). It should be
noted that this result was obtained despite the fact that
the proportion of children classified as LGA by INTER-
GROWTH21st was significantly higher than using the
customized method (25.6% vs. 13.2%) and it is explained
why the majority (86.2%) of LGA children according to
IG but AGA according to the custom method presented
a normal PI. This difference should also be interpreted
with caution since the RRs found showed wide confi-
dence intervals and since, the subsequent comparison of
both RRs showed that the differences found were not
statistically significant (p = 0.19).
Further, our analysis of the accuracy of each method
for identification of newborns with a PI > p90 revealed
that the customized method had a greater LR+, 5.40,
than the LR+, 2.54, using INTERGROWTH21st. Hence,
using customized curves, it is 5.40 times more likely that
an over nourished newborn will be classified as LGA
than a normally nourished newborn will be classified as
LGA. Given that in GDM it is critical to identify fetal
overnutrition, we consider of special relevance the differ-
ences found in the PPV of both methods to identify a PI
> p90. Using our customized curves, the probability that
a fetus classified as LGA has a PI >90th centile is 51.61%
while using INTERGROWTH21st the probability drops
to 32.20%. These results are consistent with those found
by Gonzalez et al. [36] However, in our study, an ana-
lysis of the ROC curves shows that the AUC obtained by
both methods is very similar and the small difference
observed (0.70 vs. 0.68) is not statistically significant.
Again, it should be noted that, with the prevalence of
newborns with PI>90th centile, the lack of significance
could be due to an insufficient sample size since 1603
individuals would have been required to have a statistical
power of 80%.
Another aspect worth discussing is the low sensitivity
of both methods to identify newborns under-nourished
in fetuses classified as SGA. However, in the same case,
the specificity is acceptable. In our opinion, this shows
that the same cut-off point (10th centile for SGA) can
classify a child as normal or small depending on the ref-
erence curve.
The relatively small sample lead to our primary limita-
tions, including occasional RRs with overlapping or wide
confidence intervals, which hampered their interpret-
ation. However, the relative risks were usually large
enough to be taken clinically relevant. It should be noted
that the premises from which we started when estimat-
ing the sample size have not been fulfilled. In our esti-
mation, we assumed a ratio between non-exposed /
exposed of 8. This was based on the premise that we
would find approximately 10% SGA and 10% LGA with
each method. However, using INTERGROWTH21st, for
example, we found 163 AGA and only 11 SGA. This
makes the non-exposed / exposed ratio rise to 14.8.
With this ratio, we would have needed 488 AGA
Fig. 2 ROC curves of INTERGROWTH21st and customized method in the identification of overnourished newborns. Newborns classified as LGA or
AGA have been included for each of the methods, setting the 90th centile as a cut-off point. The test has been considered positive when the
birth weight index has been found above 90th centile
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newborns to obtain significance (and this to detect a
minimum risk of 3; to detect a minimum risk of 2.5 -
which is the observed one - we would need an even lar-
ger sample: 51 SGA and 751 AGA). Therefore, although
in general our study seems to indicate that the custom-
ized method could surpass INTERGROWTH21st in the
identification of alterations in nutritional status, we
think that it is necessary to complement this study with
a larger sample.
In addition, selection and information biases could
affect the estimated of the performance of the two refer-
ence curves. We believe that our results can be extrapo-
lated to other populations of pregnant women with
adequate monitoring because obstetricians, endocrinolo-
gists, family doctors and primary care midwives moni-
tored the pregnant woman with GDM using criteria for
diagnosis, follow-up and treatment established by the
Spanish Society of Gynecology and Obstetrics.
Conclusions
Overall, there does seem to be a difference in perform-
ance between the method customized and INTER-
GROWTH21st. Our results show that customized LGA
and SGA may be better identifying nutritional status as
assessed by PI in diabetic mothers. However, further
studies with a larger sample size are necessary to in-
crease the reliability of these findings.
In our opinion, if our results are confirmed, the
greater capacity of the customized curves to identify
newborns with PI > p90 may have important implication
for monitoring pregnant women with GDM because
intrauterine identification of overnutrition may indicate
poor maternal metabolic control and the need for ex-
treme dietary care or, even, insulin treatment.
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